Insights into the Pathogenesis of Pancreatic Cystic Neoplasms

Vrishketan Sethi, Bhuwan Giri, Ashok Saluja, Vikas Dudeja

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

With the current epidemic of diagnosed pancreatic cystic neoplasms on the rise, a substantial amount of work has been done to unravel their biology, thus leading to implications on clinical decision making. Recent genetic profiling of resected human specimens has identified alterations in signaling pathways involving KRAS and GNAS signaling as early events in the pathogenesis of intraductal pancreatic mucinous neoplasms. Progressively, mutations in genes such as TP53, SMAD4, RNF43, and others are thought to characterize invasive and advanced lesions. The role of inflammation in fueling the growth and transformation of these cysts has also begun to be studied with greater interest. A number of promising clinical studies have attempted to integrate these genetic insights into classifying these cysts and treating patients. We have reviewed existing literature on similar lines besides commenting on some useful animal models that recapitulate molecular and phenotypic progression of these cysts.

Original languageEnglish (US)
Pages (from-to)1778-1786
Number of pages9
JournalDigestive Diseases and Sciences
Volume62
Issue number7
DOIs
StatePublished - Jul 1 2017

Fingerprint

Pancreatic Neoplasms
Cysts
Animal Models
Inflammation
Mutation
Growth
Genes

Keywords

  • GNAS
  • Intraductal pancreatic mucinous neoplasm
  • KRAS
  • Mucinous cystic neoplasm
  • Pancreatic cystic neoplasms
  • RNF43
  • Serous cystadenoma

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Cite this

Insights into the Pathogenesis of Pancreatic Cystic Neoplasms. / Sethi, Vrishketan; Giri, Bhuwan; Saluja, Ashok; Dudeja, Vikas.

In: Digestive Diseases and Sciences, Vol. 62, No. 7, 01.07.2017, p. 1778-1786.

Research output: Contribution to journalReview article

@article{9305494758fd4d5294d0265bd216420f,
title = "Insights into the Pathogenesis of Pancreatic Cystic Neoplasms",
abstract = "With the current epidemic of diagnosed pancreatic cystic neoplasms on the rise, a substantial amount of work has been done to unravel their biology, thus leading to implications on clinical decision making. Recent genetic profiling of resected human specimens has identified alterations in signaling pathways involving KRAS and GNAS signaling as early events in the pathogenesis of intraductal pancreatic mucinous neoplasms. Progressively, mutations in genes such as TP53, SMAD4, RNF43, and others are thought to characterize invasive and advanced lesions. The role of inflammation in fueling the growth and transformation of these cysts has also begun to be studied with greater interest. A number of promising clinical studies have attempted to integrate these genetic insights into classifying these cysts and treating patients. We have reviewed existing literature on similar lines besides commenting on some useful animal models that recapitulate molecular and phenotypic progression of these cysts.",
keywords = "GNAS, Intraductal pancreatic mucinous neoplasm, KRAS, Mucinous cystic neoplasm, Pancreatic cystic neoplasms, RNF43, Serous cystadenoma",
author = "Vrishketan Sethi and Bhuwan Giri and Ashok Saluja and Vikas Dudeja",
year = "2017",
month = "7",
day = "1",
doi = "10.1007/s10620-017-4603-1",
language = "English (US)",
volume = "62",
pages = "1778--1786",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Plenum Publishers",
number = "7",

}

TY - JOUR

T1 - Insights into the Pathogenesis of Pancreatic Cystic Neoplasms

AU - Sethi, Vrishketan

AU - Giri, Bhuwan

AU - Saluja, Ashok

AU - Dudeja, Vikas

PY - 2017/7/1

Y1 - 2017/7/1

N2 - With the current epidemic of diagnosed pancreatic cystic neoplasms on the rise, a substantial amount of work has been done to unravel their biology, thus leading to implications on clinical decision making. Recent genetic profiling of resected human specimens has identified alterations in signaling pathways involving KRAS and GNAS signaling as early events in the pathogenesis of intraductal pancreatic mucinous neoplasms. Progressively, mutations in genes such as TP53, SMAD4, RNF43, and others are thought to characterize invasive and advanced lesions. The role of inflammation in fueling the growth and transformation of these cysts has also begun to be studied with greater interest. A number of promising clinical studies have attempted to integrate these genetic insights into classifying these cysts and treating patients. We have reviewed existing literature on similar lines besides commenting on some useful animal models that recapitulate molecular and phenotypic progression of these cysts.

AB - With the current epidemic of diagnosed pancreatic cystic neoplasms on the rise, a substantial amount of work has been done to unravel their biology, thus leading to implications on clinical decision making. Recent genetic profiling of resected human specimens has identified alterations in signaling pathways involving KRAS and GNAS signaling as early events in the pathogenesis of intraductal pancreatic mucinous neoplasms. Progressively, mutations in genes such as TP53, SMAD4, RNF43, and others are thought to characterize invasive and advanced lesions. The role of inflammation in fueling the growth and transformation of these cysts has also begun to be studied with greater interest. A number of promising clinical studies have attempted to integrate these genetic insights into classifying these cysts and treating patients. We have reviewed existing literature on similar lines besides commenting on some useful animal models that recapitulate molecular and phenotypic progression of these cysts.

KW - GNAS

KW - Intraductal pancreatic mucinous neoplasm

KW - KRAS

KW - Mucinous cystic neoplasm

KW - Pancreatic cystic neoplasms

KW - RNF43

KW - Serous cystadenoma

UR - http://www.scopus.com/inward/record.url?scp=85019184526&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019184526&partnerID=8YFLogxK

U2 - 10.1007/s10620-017-4603-1

DO - 10.1007/s10620-017-4603-1

M3 - Review article

C2 - 28500587

AN - SCOPUS:85019184526

VL - 62

SP - 1778

EP - 1786

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 7

ER -